DuPont de Nemours, Inc. (BCBA:DD)
| Market Cap | 29.46T -41.0% |
| Revenue (ttm) | 10.35T +49.3% |
| Net Income | 81.48B |
| EPS | 120.37 |
| Shares Out | n/a |
| PE Ratio | 386.47 |
| Forward PE | 18.72 |
| Dividend | 486.98 (1.05%) |
| Ex-Dividend Date | Nov 30, 2026 |
| Volume | 41 |
| Open | 46,820 |
| Previous Close | 46,400 |
| Day's Range | 46,520 - 47,200 |
| 52-Week Range | 30,180 - 73,500 |
| Beta | 1.25 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 3, 2026 |
About DuPont de Nemours
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets,... [Read more]
News
DuPont de Nemours Slides: Q3 2026
DuPont de Nemours has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 3, 2026.
DuPont de Nemours Earnings release: Q3 2026
DuPont de Nemours released its Q3 2026 earnings on November 3, 2026, summarizing the period's financial results.
DuPont Swings to a Profit and Lifts Outlook
DuPont swung to a third-quarter profit of $123 million, or 91 cents a share, from a loss of $123 million, or 88 cents a share, a year earlier.
DuPont reports Q3 adjusted EPS $2.09, consensus $1.88
Reports Q3 revenue $1.87B, consensus $1.84B. “We delivered another quarter of consistent, high-quality performance, once again exceeding our financial guidance,” said Lori Koch, DuPont (DD) Chief Exec...
DuPont raises full-year profit forecasts on strong healthcare, aerospace demand
DuPont raises full-year profit forecasts on strong healthcare, aerospace demand
DuPont Reports Third Quarter 2026 Results
Exceeds Third Quarter 2026 Guidance Raises Full Year 2026 Guidance Third Quarter 2026 Highlights Net Sales of $1.9 billion increased 4%; organic sales increased 5% versus year-ago period GAAP Income f...
DuPont Net-Zero Climate Targets Validated by Science Based Targets initiative
SBTi validation recognizes DuPont's continued climate progress, with new 2035 emissions-reduction targets and a 2050 net-zero target WILMINGTON, Del., Oct. 29, 2026 /PRNewswire/ -- DuPont (NYSE: DD) t...
duPont REGISTRY Group to Showcase Lineup of Supercars at Concours at Wynn Las Vegas
MIAMI--(BUSINESS WIRE)--duPont REGISTRY Group to Showcase Lineup of Supercars at Concours at Wynn Las Vegas.
DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therapeutics
New silica-based chromatography media helps biopharmaceutical manufacturers achieve demanding purity targets while supporting integrated purification workflows from crude purification through final po...
DuPont price target lowered to $160 from $176 at RBC Capital
RBC Capital analyst Arun Viswanathan lowered the firm’s price target on DuPont (DD) to $160 from $176 and keeps an Outperform rating on the shares as part of a broader…
DuPont Announces Regular Quarterly Dividend on Common Stock
WILMINGTON, Del., Oct. 13, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the outstanding Comm...
DuPont initiated with an Overweight at Barclays
Barclays analyst Aleksey Yefremov initiated coverage of DuPont (DD) with an Overweight rating and $156 price target
DuPont downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Chigusa Katoku downgraded DuPont (DD) to Neutral from Overweight with a price target of $145, down from $172. JPMorgan also removed DuPont from its Analyst Focus List. The…
DuPont price target lowered to $162 from $170 at Citi
Citi analyst Patrick Cunningham lowered the firm’s price target on DuPont (DD) to $162 from $170 and keeps a Buy rating on the shares. The firm adjusted targets in the…
DuPont Schedules Third Quarter 2026 Earnings Conference Call
WILMINGTON, Del., Oct. 6, 2026 /PRNewswire/ -- DuPont (NYSE: DD) will release its third quarter 2026 financial results at 6:00 a.m.
DuPont Announces Winners of Third Annual Tyvek® Sustainable Healthcare Packaging Awards
Awards recognize continued excellence in healthcare packaging initiatives that utilize Tyvek ® material to help drive and promote sustainable innovation WILMINGTON, Del., Oct. 5, 2026 /PRNewswire/ -- ...
DuPont price target lowered to $172 from $178 at UBS
UBS lowered the firm’s price target on DuPont (DD) to $172 from $178 and keeps a Buy rating on the shares.
DuPont launches Sugar Separation Advisor
DuPont (DD) launched the DuPont Sugar Separation Advisor, an interactive digital tool designed to help sugar and sweetener manufacturers quickly evaluate chromatographic separation potential and ident...
DuPont Launches Sugar Separation Advisor to Accelerate Sugar and Sweetener Purification
Digital tool draws on extensive laboratory separation data to help sugar and sweetener producers identify best-fit DuPont™ AmberLite™ chromatography resins for Food & Beverage ingredient applications....
3M, DuPont must face Connecticut firefighters' lawsuit over 'forever chemicals'
A federal judge on Tuesday said more than 20 defendants including 3M , DuPont and Honeywell must face claims by Connecticut firefighters who said their protective gear was contaminated by toxic "fore...
DuPont Launches Tyvek® with Renewable Attribution for Consumer & Industrial Applications
Enabling customers to achieve more sustainable material sourcing without changing how they use Tyvek ® WILMINGTON, Del., Sept. 15, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced the global lau...
Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination
DALLAS--(BUSINESS WIRE)--Baron & Budd has secured a $380 million settlement with DuPont, The Chemours Company, and Corteva on behalf of 11 North Carolina public entities to resolve claims arising from...
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
Chemours , DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina and 11 local entities over PFAS contamination claims tied to Chemours' Fayetteville Works plant and ot...
DuPont Chemours and Corteva resolve PFAS-related claims in NC
DuPont (DD) announced that, together with Chemours (CC) and Corteva (CTVA) and its subsidiary EIDP, it has entered into a settlement with the State of North Carolina and 11 local…
Chemours, DuPont and Corteva resolve PFAS claims with $455M settlement
Chemours (CC) announced that, along with DuPont (DD) and Corteva (CTVA), it has entered into a settlement with the State of North Carolina and 11 local entities in the vicinity…